School of Pharmacy, Wenzhou Medical College, Wenzhou, China.
Toxicol Appl Pharmacol. 2012 Oct 15;264(2):212-21. doi: 10.1016/j.taap.2012.08.003. Epub 2012 Aug 10.
Fibroblast growth factor-21 (FGF21) is a potential metabolic regulator with multiple beneficial effects on metabolic diseases. FGF21 is mainly expressed in the liver, but is also found in other tissues including the intestine, which expresses β-klotho abundantly. The intestine is a unique organ that operates in a physiologically hypoxic environment, and is responsible for the fat absorption processes including triglyceride breakdown, re-synthesis and absorption into the portal circulation. In the present study, we investigated the effects of hypoxia and the chemical hypoxia inducer, cobalt chloride (CoCl(2)), on FGF21 expression in Caco-2 cells and the consequence of fat accumulation. Physical hypoxia (1% oxygen) and CoCl(2) treatment decreased both FGF21 mRNA and secreted protein levels. Gene silence and inhibition of hypoxia-inducible factor-α (HIFα) did not affect the reduction of FGF21 mRNA and protein levels by hypoxia. However, CoCl(2) administration caused a significant increase in oxidative stress. The addition of n-acetylcysteine (NAC) suppressed CoCl(2)-induced reactive oxygen species (ROS) formation and completely negated CoCl(2)-induced FGF21 loss. mRNA stability analysis demonstrated that the CoCl(2) administration caused a remarkable reduction in FGF21 mRNA stability. Furthermore, CoCl(2) increased intracellular triglyceride (TG) accumulation, along with a reduction in mRNA levels of lipid lipase, hormone sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), and an increase of sterol regulatory element-binding protein-1c (SREBP1c) and stearoyl-coenzyme A (SCD1). Addition of both NAC and recombinant FGF21 significantly attenuated the CoCl(2)-induced TG accumulation. In conclusion, the decrease of FGF21 in Caco-2 cells by chemical hypoxia is independent of HIFα, but dependent on an oxidative stress-mediated mechanism. The regulation of FGF21 by hypoxia may contribute to intestinal lipid metabolism and absorption.
成纤维细胞生长因子 21(FGF21)是一种潜在的代谢调节因子,对代谢性疾病有多种有益作用。FGF21 主要在肝脏中表达,但也在其他组织中表达,包括富含β-klotho 的肠道。肠道是一种独特的器官,在生理缺氧环境中运作,负责脂肪吸收过程,包括甘油三酯分解、重新合成和吸收到门静脉循环中。在本研究中,我们研究了缺氧和化学缺氧诱导剂氯化钴(CoCl(2))对 Caco-2 细胞中 FGF21 表达的影响及其对脂肪积累的影响。物理缺氧(1%氧气)和 CoCl(2)处理均降低了 FGF21 mRNA 和分泌蛋白水平。基因沉默和缺氧诱导因子-α(HIFα)抑制不影响缺氧引起的 FGF21 mRNA 和蛋白水平降低。然而,CoCl(2)给药会导致氧化应激显著增加。添加 N-乙酰半胱氨酸(NAC)可抑制 CoCl(2)诱导的活性氧(ROS)形成,并完全消除 CoCl(2)诱导的 FGF21 损失。mRNA 稳定性分析表明,CoCl(2)给药导致 FGF21 mRNA 稳定性显著降低。此外,CoCl(2)增加了细胞内甘油三酯(TG)的积累,同时降低了脂肪酶、激素敏感脂肪酶(HSL)和脂肪甘油三酯脂肪酶(ATGL)的 mRNA 水平,增加了固醇调节元件结合蛋白-1c(SREBP1c)和硬脂酰辅酶 A(SCD1)。添加 NAC 和重组 FGF21 均可显著减轻 CoCl(2)诱导的 TG 积累。总之,化学缺氧引起的 Caco-2 细胞中 FGF21 的减少与 HIFα无关,但依赖于氧化应激介导的机制。缺氧对 FGF21 的调节可能有助于肠道脂质代谢和吸收。